| Similar Articles |
|---|
 |
The Motley Fool
May 6, 2008
Steven Renaldi |
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry.   |
The Motley Fool
October 6, 2008
Brian Orelli |
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated. |
The Motley Fool
April 7, 2011
Brandon Glenn |
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. |
The Motley Fool
November 7, 2007
Billy Fisher |
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. |
The Motley Fool
July 1, 2004
W.D. Crotty |
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. |
The Motley Fool
October 28, 2004
Brian Gorman |
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. |
The Motley Fool
June 13, 2006
Ryan Fuhrmann |
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. |
The Motley Fool
May 20, 2004
Tom Taulli |
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. |
The Motley Fool
January 30, 2006
Brian Gorman |
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. |
The Motley Fool
August 3, 2006
Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. |
The Motley Fool
June 28, 2005
Brian Gorman |
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. |
The Motley Fool
July 28, 2004
Brian Gorman |
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. |
The Motley Fool
August 24, 2011
Brandon Glenn |
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? |
The Motley Fool
September 30, 2008
Brian Orelli |
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? |
The Motley Fool
August 18, 2004
Jeff Hwang |
Is Applied Materials Losing Momentum? The company posted a strong third quarter, but a less optimistic outlook has its shares near its 52-week low. |
The Motley Fool
January 26, 2007
Billy Fisher |
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note. |
The Motley Fool
October 26, 2005
Stephen D. Simpson |
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. |
The Motley Fool
September 2, 2009
Brian Orelli |
Should You Buy This Spinoff? Cardinal Health kicks its baby out of the nest. |
BusinessWeek
November 24, 2003
Roger O. Crockett |
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. |
The Motley Fool
May 2, 2005
Brian Gorman |
Cardinal Health Perks Up The drug distribution company is working through its problems, which should make for a brighter fiscal 2006. Investors, take note. |
The Motley Fool
January 2, 2004
Alyce Lomax |
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. |
The Motley Fool
March 23, 2011
Jordan DiPietro |
Should You Buy and Hold Cardinal Health? Does this company have the traits of a good retirement stock? |
The Motley Fool
August 5, 2005
John Reeves |
Cardinal's Mixed Bag: Fool by Numbers Cardinal Health released fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
October 8, 2007
Billy Fisher |
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. |
The Motley Fool
January 18, 2005
Brian Gorman |
Cardinal Doesn't Get Ruffled The drug distributor's potential loss of Japanese pharmaceutical Eisai will hurt in the short term, but fortunately for investors Cardinal Health continues to plan wisely. |
The Motley Fool
May 6, 2005
W.D. Crotty |
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. |
The Motley Fool
November 8, 2011
Brandon Glenn |
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity. |
BusinessWeek
August 30, 2004
Gene G. Marcial |
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. |
The Motley Fool
December 10, 2004
Brian Gorman |
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. |
The Motley Fool
October 12, 2004
W.D. Crotty |
A Bargain in Drug Distribution? D&K Healthcare Resources' stock surprises investors, but the drop brings a favorable valuation. |
The Motley Fool
March 14, 2008
Stephen Albainy-Jenei |
The War on (the Cost of) Drugs Pharmaceutical companies could be hurt by countries disregarding drug patents. |
The Motley Fool
September 9, 2011
Brandon Glenn |
Cardinal Health Looks to PET Drugs to Drive Margins The nuclear medicine business is an important driver of higher margins for the drug distribution company. |
The Motley Fool
January 21, 2005
Rich Duprey |
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. |
Chemistry World
March 3, 2015
Phillip Broadwith |
J&J to sell cardiac devices to wholesaler Cardinal Johnson & Johnson has agreed to sell its cardiovascular surgical devices subsidiary, Cordis, to wholesale supplier Cardinal Health. |
The Motley Fool
October 21, 2010
Anand Chokkavelu |
6 Health-Care Stocks Near 52-Week Lows Here are the largest health care equipment and services companies (by market cap) that are hugging 52-week lows: Medtronic... Covidien... Stryker... Becton, Dickinson and Company... McKesson... Cardinal Health... |
Pharmaceutical Executive
September 1, 2006
Reznick & Kobak |
Legal: Authorized Generics: Still Legal--and Holding Despite the rattle and hum, courts continue to support the practice of authorized generics. The response? Generic manufacturers are changing the way they argue these cases. |
| Knowledge@Wharton |
Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies? |
The Motley Fool
June 27, 2011
Brandon Glenn |
Cardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other) Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health has had an apparent change of opinion. |
The Motley Fool
December 22, 2010
Seth Jayson |
Here's How McKesson Is Making So Much for You With TTM margins all at a five-year high, McKesson looks like it's doing great. |
The Motley Fool
August 5, 2005
Stephen D. Simpson |
Can This Cardinal Sing? If Cardinal Health succeeds in its plans to return more capital to shareholders, this could become an interesting income play. This stock is worth keeping an eye on for the future. |
Managed Care
September 2007
Martin Sipkoff |
Patent Law Rulings Work in Favor of Generics Thanks to recent Supreme Court rulings, manufacturers of generic drugs are in a good position to continue expansion of their market share. |
CIO
March 1, 2001
Tracy Mayor |
Someone to Watch Over You A single sentinel in charge of security, both physical and digital, makes sense for this company. Does it make sense for yours? |
Chemistry World
August 23, 2012
Dean Baker |
Monopoly money It is remarkable that the system of patent support for prescription drug research has not become more of a policy issue. |
